Empreendimentos Pague Menos (PGMN3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Achieved 17.1% year-over-year gross revenue growth in Q1 2025, reaching R$3.6 billion, with same-store sales up 17% and strong digital channel expansion.
Adjusted EBITDA rose 55.2% to R$150.3 million, with margin up 1 percentage point to 4.1%.
Net income was R$13.1 million for the quarter, reversing a loss in Q1 2024; LTM net income reached R$188.2 million, up 5x year-over-year.
Market share increased to 6.5% nationally, with gains in all regions and six consecutive quarters of share growth.
Digital channels revenue rose 53.6% to R$639 million, now 17.6% of total sales.
Financial highlights
Gross profit reached R$1,041.1 million, with margin at 28.7% of gross revenue.
Operating cash flow (LTM) was R$487 million, up 16% year-over-year; cash flow from operations reached R$678.8 million LTM, up 4x year-over-year.
Net debt/EBITDA improved to 1.9x from 2.8x in Q1 2024.
G&A expenses at 2.4–2.5% of revenue, the lowest in five years.
Inventory turnover improved, with a 9-day reduction in inventory and a 10-day improvement in the cash cycle.
Outlook and guidance
Management remains optimistic, targeting further acceleration in growth, operational improvements, and digital expansion.
Plans to open 50 new stores in 2025, with a lower investment level to prioritize deleveraging.
Focus on reducing leverage further by year-end, with no specific guidance on the final level.
Strategic plan execution and integration of Extrafarma expected to drive further gains.
Latest events from Empreendimentos Pague Menos
- Record 2025 growth in revenue, profit, and market share, with strong digital and operational gains.PGMN3
Q4 20252 Mar 2026 - Revenue and profit surged on strong sales, margin expansion, and synergy capture.PGMN3
Q2 20242 Feb 2026 - Record sales, margin gains, and lower leverage highlight strong operational momentum.PGMN3
Q3 202416 Jan 2026 - Record sales, margin expansion, and synergy capture drive robust growth and deleveraging.PGMN3
Q4 202419 Dec 2025 - Record sales and profit growth fueled by digital and operational gains.PGMN3
Q2 202523 Nov 2025 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202513 Nov 2025 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025 - Nationwide Health Hub and digital innovation fuel PagueMenos extrafarma’s rapid, profitable growth.PGMN3
Investor Presentation16 Jun 2025